🚨 Final call for abstract submissions for #MAP2024 Don't miss this opportunity to showcase your research and connect with the global #PrecisionMedicine community. Share your findings, receive invaluable feedback, and get your abstract published in the ESMO open-access journal. ⏰ You have until 8 pm (UK time) today to submit. Submit now: bit.ly/3UIXwaF Unicancer | ESMO - European Society for Medical Oncology
Cancer Research UK Science and Innovation
Research Services
We’re the world’s leading cancer charity dedicated to saving lives through research, influence and information.
About us
At Cancer Research UK, we want to bring about a world where everybody can lead longer, better lives, free from the fear of cancer. Research holds the key to making this a reality. We’re here to help our research community connect globally, share opportunities for funding and events across our network and showcase the exciting research that’s unlocking new ways to prevent, diagnose and treat cancer.
- Website
-
http://cruk.org/science
External link for Cancer Research UK Science and Innovation
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- London
Updates
-
Our portfolio of #ClinicalResearch has led to advances in cancer prevention, detection and treatment over the years, but are we doing enough? With the launch of our new clinical funding scheme, Graham Cadwallader, Head of clinical research, talks to us about the bold changes we’re making to the way we fund clinical research. He shares insights into how we’re maximising the value of data and samples, focusing on early-phase proof-of-concept trials, and optimising treatments whilst minimising adverse effects for patients. Read more from Graham 👉 https://bit.ly/3Y0J29s
-
-
🗣 Announcing a new clinical research funding scheme, set to replace our current clinical funding schemes. Opening in September 2024, this single, scalable and flexible scheme supports high-quality clinical studies that address important clinical questions and enhances our understanding of biological mechanisms, to inform more effective and kinder treatments. The funding scheme comprises three interconnected modules: clinical trials, experimental medicine, and sample collections, where you can ask for what you need to do the research you wish to do. Explore the funding scheme 👉 https://bit.ly/4bpK6qg #ClincialResearch #CRUKFunding #ClinicalTrials
-
-
Cancer Research UK Science and Innovation reposted this
🔬 We are so proud to fund #STARS2024, our major equality, diversity and inclusion initiative that aims to inspire the next generation of research scientists. 👇 Read Professor John F Marshall's blog about his big ambitions for the programme.
“STARS made such a difference to me… I got a real insight into how science underpins the study of medicine.” This comment from an alumnus of the Science Training for Aspiring Research Scientists (STARS) programme sums up its purpose. I launched STARS at the Barts Cancer Institute (Queen Mary University of London) in 2013, offering a week’s laboratory work experience and careers guidance to aspiring scientists studying for their A-levels. This year, STARS is expanding, and we will welcome nearly fifty students into labs across London. At the end of the programme, we hope these young people will leave with a clearer understanding of the day-to-day work of a researcher and the many career options that flow from a science degree, as well as an appreciation of how rigorous research supports life-changing medicine. More importantly, we want to make a difference to them as individuals – these brilliant students should feel inspired and empowered to apply to competitive courses at top universities. They have been selected from schools with historically low university attendance, but over the 11 years since I launched STARS, we have seen many alumni go on to study science, medicine and scientific research at Russell Group universities and other amazing careers. They may have entered the lab with low self-confidence or low expectations of themselves, but the goal of the STARS programme is to get them to realise their potential and help them to shine. Fantastic news for #STARS2024 is that we have secured funding and support from the Cancer Research UK City of London Centre, which has a firm commitment to supporting equality, diversity and inclusion in scientific research. So STARS is growing this year to include laboratories at King's College London College London and UCL, as well as welcoming students to Barts Cancer Institute (Queen Mary University of London), and to the Blizard Institute. It is my hope that STARS will continue to expand, and I would be delighted to support other universities interested in delivering the programme. Every secondary school has students with the skills to succeed in science, but not all these young people will have the contacts or confidence to organise work experience in advance of university applications. As researchers, we have a duty to support the next generation. This year’s cohort are already off to a blazing start, and I know they will make the most of this week’s fascinating and practical programme, with a mixture of hands-on lab work and informative sessions with our admissions teams. I firmly believe that some of these young people could make the breakthroughs, develop the treatments and provide the care that could change our world. STARS will help them to believe this for themselves.
-
-
The journey to drug development and success is never easy, and spin-out company Myricx Bio knows this all too well. Recently securing one of the largest Series A investments, Myricx Bio has developed first-in-class N-myristoyltransferase (NMT) inhibitors as #ADC payloads, showing promising preclinical results with complete and durable tumour regression. Now on the path to the clinic, we spoke with co-founder Ed Tate. He shared their remarkable journey, from targeting anti-malarial treatments and potentially curing the common cold to developing a promising oncology drug. Hear more from Ed 👉 https://bit.ly/4eOyjEW Imperial College London | The Francis Crick Institute
-
-
We are thrilled to see Edith Heard appointed as the new Director and Chief Executive of the Francis Crick Institute. We look forward to witnessing the continued advancements in biomedical research under her guidance. Congratulations 👏
We are delighted to announce that Professor Edith Heard has been appointed as our new director and chief executive. Edith, who is currently director-general at EMBL, will succeed Paul Nurse in leading the Crick from the summer of 2025. We are lucky that Paul will continue his laboratory and research at the Crick after stepping down as director and chief executive. 🔗 https://lnkd.in/e38A-P7p
-
-
Thrilled to announce the June winner of our #ResearchIsBeautiful image campaign: Michaela Macdonald from Carcinotech Ltd Michaela’s image captures a 3D-bioprinted living tumour derived from donor glioblastoma tissue. Carcinotech specialises in crafting these bioengineered tumours from patient biopsies, offering researchers and drug developers an alternative to animal models for screening and testing cancer therapies. Interested in taking part? Drop us an email by 25th of each month with your wonderful moments of science to win our monthly pick. T&Cs apply. https://lnkd.in/efB-ujNF
-
What data do we already have that can help us understand less heard voices in research and publishing? How many publications contain fabricated, falsified or plagiarised data, and how should we deal with fake studies? The latest in our Research with Integrity series sees Andrew Porter (Research Integrity and Training Adviser at CRUK MI), Catherine Winchester (Head of the Research Integrity Service at our Scotland Institute) and the wider research integrity team give us the low-down of #ResearchIntegrity from the 8th World Conf Research Integrity #WCRI2024. Read along to find out what they think you should know about this culture change journey: https://lnkd.in/eYZGf3dn
-
-
The deadline is fast approaching🏃♂️⏰ If you're working on an exciting project in #PrecisionMedicine or molecular analysis, now is the time to share your innovative work with the research community. Submit your abstract by 23 July for the chance to showcase your research to leading experts in the field. Hear from our scientific co-chairs, Lisa Derosa (Gustave Roussy), Mariam Jamal-Hanjani (UCL) and Joaquin Mateo (Vall d'Hebron Institute of Oncology (VHIO)), on why you should submit an abstract for #MAP2024 👉 https://bit.ly/3R7JrT5 Learn more and submit your abstract here: https://bit.ly/3UIXwaF ESMO - European Society for Medical Oncology Unicancer
Why you should submit your abstract for MAP 2024
https://www.youtube.com/
-
Our first ever annual Cancer Prevention Research Conference in partnership with the American Cancer Society and the National Cancer Institute (NCI) just took place in Boston. During these last three days, we had the opportunity to engage with over 350 attendees from all over the world to discuss the latest concepts in cancer prevention research. As we reflect on the insights gained from this first event, we’re happy to announce that Cancer Research UK will be hosting the 2025 conference in London, between 18 – 20 June. Mark the date in your calendars and register your interest to be the first one to hear about when the registration opens. 🗓 Register your interest now: https://bit.ly/4cwakIU Anbalakan Paramasivam | Timothy Rebbeck | David Crosby | William Dahut | John Burn | Jessica Faupel-Badger | Catherine Elliott | Thea Tlsty | Harvard University | Newcastle University | Cancer Research UK (CRUK) | #PrevConf24
-